Kineta Secures $1,752,688 New Financing

  • Feed Type
  • Date
    6/21/2016
  • Company Name
    Kineta
  • Mailing Address
    219 Terry Ave N Seattle, WA 98109 USA
  • Company Description
    Through Kineta, our pioneering team is dedicated to further study of innate immunity with an aggressive strategy to develop early stage programs for powerful new antiviral and immune modulating drugs.
  • Website
    http://www.kinetabio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $1,752,688
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 20 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy